HALO logo
halo search icon
GOSS
Gossamer Bio, Inc.

GOSS · Gossamer Bio, Inc.

0.14

USD
-0.0065 (-4.561%)
24/07/2026 04:00:00 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

US$66.48M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 24/07/2026 04:00:00 PM

Price Chart

Description

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 26, 2015 and is headquartered in San Diego, CA.

  • All-Companies
  • All-Consensus
  • HALO All
  • HALO Consensus Value
  • HALO Earnings Momentum

Key Fundamentals

EPS 3 yr Growth

-92.00%

EBITDA Margin

-48.60%

Operating Cashflow

-$3m

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

-4.80

Quick Ratio

6.90

Performance

52 weeks range

Low 0.11 - 3.87

Trade Value (12mth)

US$2,128,619.00

1 week

-16.42%

1 month

-15.68%

YTD

-95.05%

1 year

-91.99%

All time high

27.15

Additional Data

Shares Outstanding (Fully Diluted)

227m

HALO Sector

Healthcare

Next Company Report Date

12-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Weak

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
15 July 26EDG
15 July 26EDG
01 July 26EDG
17 June 26EDG
05 June 26EDG

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Gossamer Bio, Inc. (GOSS:NAS)?
Halo FAQ
The current share price of Gossamer Bio, Inc. (GOSS:NAS) is USD$0.14.
2
What is the 52-week high share price for Gossamer Bio, Inc. (GOSS:NAS)?
Halo FAQ
The 52-week high share price for Gossamer Bio, Inc. (GOSS:NAS) is USD$3.87.
3
What is the 52-week low share price for Gossamer Bio, Inc. (GOSS:NAS)?
Halo FAQ
The 52-week low share price for Gossamer Bio, Inc. (GOSS:NAS) is USD$0.11.
4
What is the dividend yield for Gossamer Bio, Inc. (GOSS:NAS)?
Halo FAQ
Gossamer Bio, Inc. (GOSS:NAS) does not pay a dividend.
5
What was Gossamer Bio, Inc. (GOSS:NAS) last dividend payment?
Halo FAQ
Gossamer Bio, Inc. (GOSS:NAS) does not pay a dividend.
6
What is the franking level for Gossamer Bio, Inc. (GOSS:NAS)?
Halo FAQ
Gossamer Bio, Inc. (GOSS:NAS) has a franking level of 0.00%.
7
In which sector is Gossamer Bio, Inc. (GOSS:NAS) classified?
Halo FAQ
Gossamer Bio, Inc. (GOSS:NAS) is classified in the Healthcare.